Disease

Alzheimer's drugs, at least the experimental ones, are a dime a dozen. Maybe less.

We examined cumulative hospitalization rates and deaths since early 2020 for states and Federal Regions[1] and focused on differences among states and possible explanations for their diversity.

The number of deaths from COVID-19 is way down from its peak and pandemic-related restrictions and mandates have virtually disappeared, but there are hints we are in for a late summer surge in infections.

I’m a pretty “zen” guy, but I will readily admit that when I go see the doctor, I have a unique form of “white coat” syndrome; I call it “wrong side of the desk” syndrome.

Which COVID outcomes are most important? Premature mortality,  should we now consider chronic symptoms (“long COVID”), or is the public health destination COVID as an “ordinary” illness”?

The CDC has reported that at least eight malaria infections in Florida and Texas have been detec

“Studies suggest that a large proportion of the adult population regularly pick their nose.

The Alpha-Gal Primer

This article summarizes an opinion piece in the Proceedings of the National Academy of Science.

The Food and Drug Administration on July 6 granted full approval to the first therapy for Alzheimer’s that slows the cognitive decline associated with the disease.